268 related articles for article (PubMed ID: 25911051)
1. Role of cathepsin D activation in major adverse cardiovascular events and new-onset heart failure after STEMI.
Yamac AH; Sevgili E; Kucukbuzcu S; Nasifov M; Ismailoglu Z; Kilic E; Ercan C; Jafarov P; Uyarel H; Bacaksiz A
Herz; 2015 Sep; 40(6):912-20. PubMed ID: 25911051
[TBL] [Abstract][Full Text] [Related]
2. Non-O blood groups can be a prognostic marker of in-hospital and long-term major adverse cardiovascular events in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Cetin MS; Ozcan Cetin EH; Aras D; Topaloglu S; Temizhan A; Kisacik HL; Aydogdu S
Thromb Res; 2015 Sep; 136(3):599-605. PubMed ID: 26251078
[TBL] [Abstract][Full Text] [Related]
3. Timing and long-term prognosis of recurrent MI after primary angioplasty : Stent thrombosis vs. non-stent-related reinfarction.
Viveiros Monteiro A; Ramos R; Fiarresga A; de Sousa L; Cacela D; Patrício L; Bernardes L; Soares C; Cruz Ferreira R
Herz; 2017 Apr; 42(2):186-193. PubMed ID: 27363417
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D and prognosis in acute myocardial infarction.
Ng LL; Sandhu JK; Squire IB; Davies JE; Jones DJ
Int J Cardiol; 2013 Oct; 168(3):2341-6. PubMed ID: 23415169
[TBL] [Abstract][Full Text] [Related]
5. MR-proANP improves prediction of mortality and cardiovascular events in patients with STEMI.
Lindberg S; Jensen JS; Pedersen SH; Galatius S; Goetze JP; Mogelvang R
Eur J Prev Cardiol; 2015 Jun; 22(6):693-700. PubMed ID: 24906365
[TBL] [Abstract][Full Text] [Related]
6. Soluble form of membrane attack complex independently predicts mortality and cardiovascular events in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
Lindberg S; Pedersen SH; Mogelvang R; Galatius S; Flyvbjerg A; Jensen JS; Bjerre M
Am Heart J; 2012 Nov; 164(5):786-92. PubMed ID: 23137511
[TBL] [Abstract][Full Text] [Related]
7. Osteoprotegerin in ST-elevation myocardial infarction: prognostic impact and association with markers of myocardial damage by magnetic resonance imaging.
Fuernau G; Zaehringer S; Eitel I; de Waha S; Droppa M; Desch S; Schuler G; Adams V; Thiele H
Int J Cardiol; 2013 Sep; 167(5):2134-9. PubMed ID: 22704876
[TBL] [Abstract][Full Text] [Related]
8. Impact of D-dimer level on postinterventional coronary flow and in-hospital MACE in ST-segment elevation myocardial infarction.
Sarli B; Akpek M; Baktir AO; Sahin O; Saglam H; Arinc H; Odabasi H; Dogan S; Kurtul S; Dogan Y; Kaya MG
Herz; 2015 May; 40(3):507-13. PubMed ID: 24441391
[TBL] [Abstract][Full Text] [Related]
9. Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Lindberg S; Pedersen SH; Mogelvang R; Jensen JS; Flyvbjerg A; Galatius S; Magnusson NE
J Am Coll Cardiol; 2012 Jul; 60(4):339-45. PubMed ID: 22813613
[TBL] [Abstract][Full Text] [Related]
10. E/e' two weeks after onset is a powerful predictor of cardiac death and heart failure in patients with a first-time ST elevation acute myocardial infarction.
Iwahashi N; Kimura K; Kosuge M; Tsukahara K; Hibi K; Ebina T; Saito M; Umemura S
J Am Soc Echocardiogr; 2012 Dec; 25(12):1290-8. PubMed ID: 23200417
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Outcomes in Survivors of Early Ventricular Arrhythmias After Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention.
Liang JJ; Fender EA; Cha YM; Lennon RJ; Prasad A; Barsness GW
Am J Cardiol; 2016 Mar; 117(5):709-13. PubMed ID: 26796195
[TBL] [Abstract][Full Text] [Related]
12. Gender differences in long-term outcome after primary percutaneous intervention for ST-segment elevation myocardial infarction.
Wijnbergen I; Tijssen J; van 't Veer M; Michels R; Pijls NH
Catheter Cardiovasc Interv; 2013 Sep; 82(3):379-84. PubMed ID: 23553888
[TBL] [Abstract][Full Text] [Related]
13. Cardiac troponin elevation pattern in patients undergoing a primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: characterization and relationship with cardiovascular events during hospitalization.
Buber J; Laish-Farkash A; Koren-Morag N; Fefer P; Segev A; Hod H; Matetzky S
Coron Artery Dis; 2015 Sep; 26(6):503-9. PubMed ID: 26061436
[TBL] [Abstract][Full Text] [Related]
14. Circulating miRNAs Related to Long-term Adverse Cardiovascular Events in STEMI Patients: A Nested Case-Control Study.
Yang X; Du X; Ma K; Li G; Liu Z; Rong W; Miao H; Zhu F; Cui Q; Wu S; Li Y; Du J
Can J Cardiol; 2021 Jan; 37(1):77-85. PubMed ID: 32735867
[TBL] [Abstract][Full Text] [Related]
15. Association between intraprocedural thrombotic events and adverse outcomes after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (a Harmonizing Outcomes With RevasculariZatiON and Stents in Acute Myocardial Infarction [HORIZONS-AMI] Substudy).
Kirtane AJ; Sandhu P; Mehran R; McEntegart M; Cristea E; Brener SJ; Xu K; Fahy M; Généreux P; Wessler JD; Stone GW
Am J Cardiol; 2014 Jan; 113(1):36-43. PubMed ID: 24169019
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance and relationship of worst lead residual ST segment elevation with myocardial damage assessed by cardiovascular MRI in myocardial infarction.
Rommel KP; Baum A; Mende M; Desch S; Gutberlet M; Schuler G; Thiele H; Eitel I
Heart; 2014 Aug; 100(16):1257-63. PubMed ID: 25049315
[TBL] [Abstract][Full Text] [Related]
17. Unstable angina pectoris prior to ST elevation myocardial infarction in patients treated with primary percutaneous coronary intervention has no influence on prognosis.
Kluz K; Parenica J; Kubkova L; Littnerova S; Tomandl J; Poloczek M; Toman O; Tesak M; Cermakova Z; Gottwaldova J; Manousek J; Pavkova Goldbergova M; Spinar J; Jarkovsky J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):251-8. PubMed ID: 24457834
[TBL] [Abstract][Full Text] [Related]
18. The impact of distal embolization and distal protection on long-term outcome in patients with ST elevation myocardial infarction randomized to primary percutaneous coronary intervention--results from a randomized study.
Lønborg J; Kelbæk H; Helqvist S; Holmvang L; Jørgensen E; Saunamäki K; Kløvgaard L; Kaltoft A; Bøtker HE; Lassen JF; Thuesen L; Terkelsen CJ; Kofoed KF; Clemmensen P; Køber L; Engstrøm T
Eur Heart J Acute Cardiovasc Care; 2015 Apr; 4(2):180-8. PubMed ID: 25013089
[TBL] [Abstract][Full Text] [Related]
19. ST-segment depression resolution predicts infarct size and reperfusion injury in ST-elevation myocardial infarction.
Reinstadler SJ; Baum A; Rommel KP; Eitel C; Desch S; Mende M; Metzler B; Poess J; Thiele H; Eitel I
Heart; 2015 Nov; 101(22):1819-25. PubMed ID: 26385452
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
